Clinical Trials Directory

Trials / Terminated

TerminatedNCT04120870

Comparison of Ketamine and Etomidate During Rapid Sequence Intubation in Trauma Patients

Comparison of Effects on Hemodynamics Between Ketamine and Etomidate During Rapid Sequence Intubation in Trauma Patients With High Shock Index

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Ajou University School of Medicine · Academic / Other
Sex
All
Age
19 Years – 70 Years
Healthy volunteers
Not accepted

Summary

In trauma patients with high shock index, the investigators compare the effects on hemodynamics between ketamine and etomidate.

Detailed description

In trauma patients, rapid sequence intubation is recommended. The drug of choice, however, has been debated. One cohort comparative study showed ketamine had benefit in hemodynamics compared to etomidate in trauma patients. One observational study showed in high shock index patients, ketamine showed maintain systolic blood pressure. And other retrospective showed less clinical hypotension was less in ketamine. However there is no randomized controlled study comparing ketamine and etomidate in trauma patients. The purpose of this study is comparing the effects of hemodynamics between ketamine and etomidate in high shock index trauma patients.

Conditions

Interventions

TypeNameDescription
DRUGEtomidate Injection 0.2 mg/kgThe induction agent of rapid sequence intubation is etomidate. 0.2 mg/kg
DRUGKetamine injection 2 mg/kgThe induction agent of rapid sequence intubation is ketamine. 2 mg/kg

Timeline

Start date
2019-10-01
Primary completion
2021-11-30
Completion
2021-12-30
First posted
2019-10-09
Last updated
2022-03-03

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04120870. Inclusion in this directory is not an endorsement.

Comparison of Ketamine and Etomidate During Rapid Sequence Intubation in Trauma Patients (NCT04120870) · Clinical Trials Directory